Aldeyra Therapeutics, Inc. (ALDX)
5.26
+0.15
(+2.94%)
USD |
NASDAQ |
Mar 04, 10:11
Aldeyra Therapeutics Research and Development Expense (Annual) : 25.66M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Assertio Holdings, Inc. | 3.822M |
| MediciNova, Inc. | 7.135M |
| Altimmune, Inc. | 81.99M |
| AbbVie, Inc. | 8.249B |
| Actinium Pharmaceuticals, Inc. | 29.88M |